Rab35-regulated lipid turnover by myotubularins represses mTORC1 activity and controls myelin growth - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue Nature Communications Année : 2020

Rab35-regulated lipid turnover by myotubularins represses mTORC1 activity and controls myelin growth

Résumé

Inherited peripheral neuropathies (IPNs) represent a broad group of disorders including Charcot-Marie-Tooth (CMT) neuropathies characterized by defects primarily arising in myelin, axons, or both. The molecular mechanisms by which mutations in nearly 100 identified IPN/CMT genes lead to neuropathies are poorly understood. Here we show that the Ras-related GTPase Rab35 controls myelin growth via complex formation with the myotubularin-related phosphatidylinositol (PI) 3-phosphatases MTMR13 and MTMR2, encoded by genes responsible for CMT-types 4B2 and B1 in humans, and found that it downregulates lipid-mediated mTORC1 activation, a pathway known to crucially regulate myelin biogenesis. Targeted disruption of Rab35 leads to hyperactivation of mTORC1 signaling caused by elevated levels of PI 3-phosphates and to focal hypermyelination in vivo. Pharmacological inhibition of phosphatidylinositol 3,5-bisphosphate synthesis or mTORC1 signaling ameliorates this phenotype. These findings reveal a crucial role for Rab35-regulated lipid turnover by myotubularins to repress mTORC1 activity and to control myelin growth.
Fichier principal
Vignette du fichier
s41467-020-16696-6.pdf (7.98 Mo) Télécharger le fichier
Loading...

Dates et versions

pasteur-02872864 , version 1 (17-06-2020)

Licence

Paternité

Identifiants

Citer

Linda Sawade, Federica Grandi, Marianna Mignanelli, Genaro Patiño-López, Kerstin Klinkert, et al.. Rab35-regulated lipid turnover by myotubularins represses mTORC1 activity and controls myelin growth. Nature Communications, 2020, 11 (1), pp.2835. ⟨10.1038/s41467-020-16696-6⟩. ⟨pasteur-02872864⟩
60 Consultations
57 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More